Harpoon Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Harpoon Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2023.
  • Harpoon Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $8.86M, a 57.6% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $8.86M +$3.24M +57.6% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $9.3M +$3.5M +60.3% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $10.4M +$4.44M +74.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $10.9M +$4.73M +77.2% Dec 31, 2022 10-Q 2023-11-09
Q3 2022 $5.62M -$660K -10.5% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $5.8M -$624K -9.72% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $5.97M -$591K -9.01% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $6.13M -$456K -6.93% Dec 31, 2021 10-K 2023-03-27
Q3 2021 $6.28M -$423K -6.31% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $6.42M -$391K -5.74% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $6.56M -$359K -5.19% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $6.58M -$432K -6.16% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $6.7M -$404K -5.69% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $6.81M -$641K -8.6% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $6.92M -$1.2M -14.8% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $7.02M Dec 31, 2019 10-K 2021-03-10
Q3 2019 $7.11M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $7.45M Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $8.12M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.